Qianhai Health (HKG:0911) forecasts a return to net profit of about HK$1.3 million in 2024 from a loss of HK$52.7 million in 2023, according to a Thursday filing with the Hong Kong bourse.

The upbeat forecast is attributable to a return to a gross profit of HK$29.7 million from a gross loss a year earlier and a one-off gain of HK$51.9 million from the sale of subsidiaries, among others, the filing said.

The healthcare products distributor plans to release full-year results in March.